Stock Market Reviews

Read and share opinions on PEN (Penumbra, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Penumbra (PEN): Examining Valuation After Recent Share Price Gains and Robust Earnings Growth
  Nov 15, 2025
• Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
  Nov 11, 2025
• Do Options Traders Know Something About Penumbra Stock We Don't?
  Nov 10, 2025
• Penumbra, Inc. Just Recorded A 29% EPS Beat: Here's What Analysts Are Forecasting Next
  Nov 8, 2025
• Penumbra price target raised to $355 from $350 at Canaccord
  Nov 7, 2025
• Penumbra Shoots For A Breakout On 'Another Impressive Quarter'
  Nov 6, 2025
• Did Strong Q3 Results and Positive CAVT Trial Outcomes Just Shift Penumbra's (PEN) Investment Narrative?
  Nov 6, 2025
• Penumbra (PEN) Q3 2025 Earnings Call Transcript
  Nov 6, 2025
• Why Penumbra (PEN) Stock Is Up Today
  Nov 6, 2025
• Penumbra Inc (PEN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and New Product ...
  Nov 6, 2025
• Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
  Nov 5, 2025
• Penumbra (PEN) Q3 Earnings and Revenues Beat Estimates
  Nov 5, 2025
• Penumbra (NYSE:PEN) Delivers Strong Q3 Numbers, Stock Jumps 18.7%
  Nov 5, 2025
• Penumbra: Q3 Earnings Snapshot
  Nov 5, 2025
• Penumbra, Inc. Reports Third Quarter 2025 Financial Results
  Nov 5, 2025
• What To Expect From Penumbra’s (PEN) Q3 Earnings
  Nov 4, 2025
• Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
  Nov 3, 2025
• Is Penumbra’s Stock Still a Good Bet After a 7% Drop in the Past Month?
  Oct 29, 2025